ProCE Banner Activity

Interactive Decision Support Tool: Expert Insight on Therapy Selection for Unresectable Stage III and Metastatic NSCLC

Tool
Use this Interactive Decision Support Tool to compare your choice of therapy for patients with NSCLC with those of 5 renowned experts.

Released: January 12, 2021

Expiration: January 11, 2022

No longer available for credit.

Share

Faculty

Matthew Gubens

Matthew Gubens, MD, MS

Associate Professor
Thoracic Oncology
University of California, San Francisco
San Francisco, California

Wade T. Iams

Wade T. Iams, MD, MSCI

Assistant Professor of Medicine
Division of Hematology/Oncology
Department of Medicine
Vanderbilt University Medical Center
Nashville, Tennessee

Heather J. Jackson

Heather J. Jackson, PhD, FNP-BC, NEA-BC, FAANP

Associate Professor
Division of Hematology/Oncology
Department of Medicine
Vanderbilt University School of Nursing
Administrative Director of Advanced Practice
Division of Hematology/Oncology
Department of Medicine
Vanderbilt University Medical Center
Nashville, Tennessee

Zofia Piotrowska

Zofia Piotrowska, MD

Assistant Professor of Medicine
Massachusetts General Hospital Cancer Center
Harvard Medical School
Boston, Massachusetts

Karen L. Reckamp

Karen L. Reckamp, MD, MS

Associate Professor
Medical Oncology and Therapeutics Research
City of Hope Comprehensive Cancer Center
Duarte, California

H. Jack West

H. Jack West, MD

Medical Director
Thoracic Oncology Program
Swedish Cancer Institute
Seattle, Washington

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Bristol Myers Squibb

Celgene

Lilly

Loxo Oncology subsidiary of Eli Lilly

Faculty Disclosure

Primary Author

Matthew Gubens, MD, MS

Associate Professor
Thoracic Oncology
University of California, San Francisco
San Francisco, California

Wade T. Iams, MD, MSCI

Assistant Professor of Medicine
Division of Hematology/Oncology
Department of Medicine
Vanderbilt University Medical Center
Nashville, Tennessee

Heather J. Jackson, PhD, FNP-BC, NEA-BC, FAANP

Associate Professor
Division of Hematology/Oncology
Department of Medicine
Vanderbilt University School of Nursing
Administrative Director of Advanced Practice
Division of Hematology/Oncology
Department of Medicine
Vanderbilt University Medical Center
Nashville, Tennessee

Heather J. Jackson, PhD, FNP-BC, NEA-BC, FAANP, has no relevant financial relationships to disclose.

Zofia Piotrowska, MD

Assistant Professor of Medicine
Massachusetts General Hospital Cancer Center
Harvard Medical School
Boston, Massachusetts

Zofia Piotrowska, MD: consultant/advisor/speaker: AstraZeneca, Bayer, Blueprint Medicines, Boehringer Ingelheim, Cullinan Oncology, Daiichi Sankyo, Eli Lilly, Janssen, Merck, Sanofi, Taiho, Takeda; researcher: AbbVie, AstraZeneca, Blueprint Medicines, Cullinan, Daiichi Sankyo, Janssen, Novartis, Spectrum, Takeda, Tasaro/GSK.

Karen L. Reckamp, MD, MS

Associate Professor
Medical Oncology and Therapeutics Research
City of Hope Comprehensive Cancer Center
Duarte, California

H. Jack West, MD

Medical Director
Thoracic Oncology Program
Swedish Cancer Institute
Seattle, Washington

Additional Information

Program Medium

This program has been made available online.